Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Financing › Details

Synaffix–Aravis: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital

	Period	2014-02-18
	Money taker	Synaffix B.V.
	Group	Lonza (Group)
	Money source	Aravis S.A.
	Group	Aravis (Group)
	Product	antibody-drug conjugate (ADC)
	Product 2	venture capital

Record changed: 2023-06-01

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Lonza (Group)

[1] Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel....
[2] Lonza Group AG. (3/20/24). "Press Release: Lonza Signs Agreement to Acquire Large-scale Biologics Site in Vacaville (US) from Roche". Basel....
[3] Cellbox Solutions GmbH. (11/1/23). "Press Release: Dr. Hartmut Tintrup Joins Cellbox Solutions GmbH as new CEO". Cologne....
[4] Lonza Group AG. (9/18/23). "Press Release: Board Announcement. CEO Pierre-Alain Ruffieux to Leave Lonza – Albert M. Baehny to Step in as CEO ad interim". Basel....
[5] PolyPeptide Group AG. (8/15/23). "Press Release: Transformational Progress Taking Shape, Profitability Impacted by Rapid Expansion – Appointment of Marc Augustin as New CFO". Baar....
[6] Lonza Group Ltd.. (6/1/23). "Press Release: Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering". Basel & Amsterdam....
[7] Synaffix B.V.. (1/5/23). "Press Release: Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs". Amsterdam....
[8] Synaffix B.V.. (1/4/23). "Press Release: Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program". Amsterdam, San Francisco, CA, et al.....
[9] Emergence Therapeutics AG. (9/6/22). "Press Release: Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal". Amsterdam & Duisburg....
[10] Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]